Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer.

Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer.

TRIAL REGISTRATION:ClinicalTrials.gov NCT03474198, NCT01659437.

Bibliographic Details
Main Authors: Paul J Converse, Deepak V Almeida, Rokeya Tasneen, Vikram Saini, Sandeep Tyagi, Nicole C Ammerman, Si-Yang Li, Nicole M Anders, Michelle A Rudek, Jacques H Grosset, Eric L Nuermberger
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-08-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC6107292?pdf=render

Internet

http://europepmc.org/articles/PMC6107292?pdf=render

Similar Items